ECSP055725A - Formulaciones nutricionales que contienen sustancias simbióticas - Google Patents

Formulaciones nutricionales que contienen sustancias simbióticas

Info

Publication number
ECSP055725A
ECSP055725A EC2005005725A ECSP055725A ECSP055725A EC SP055725 A ECSP055725 A EC SP055725A EC 2005005725 A EC2005005725 A EC 2005005725A EC SP055725 A ECSP055725 A EC SP055725A EC SP055725 A ECSP055725 A EC SP055725A
Authority
EC
Ecuador
Prior art keywords
substances
formulations containing
nutritional formulations
containing symbolic
symbolic
Prior art date
Application number
EC2005005725A
Other languages
English (en)
Inventor
Susan Marie Kaup
Jeffrey Lynn Wilson
Beverley Marie Kostek
David Curtis Frantz
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP055725A publication Critical patent/ECSP055725A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/113Acidophilus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/531Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se proporcionan composiciones nutricionales que comprenden oligofructosa, sialilactosa y bacteria probiótica, las cuales son útiles en la erradicación de microorganismos patógenos en los tractos gastrointestinales de los pacientes.
EC2005005725A 2002-10-11 2005-04-08 Formulaciones nutricionales que contienen sustancias simbióticas ECSP055725A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41810902P 2002-10-11 2002-10-11

Publications (1)

Publication Number Publication Date
ECSP055725A true ECSP055725A (es) 2005-07-06

Family

ID=32094146

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005725A ECSP055725A (es) 2002-10-11 2005-04-08 Formulaciones nutricionales que contienen sustancias simbióticas

Country Status (13)

Country Link
US (1) US20040072794A1 (es)
EP (1) EP1549151A1 (es)
CN (1) CN1703149A (es)
AU (1) AU2003282494A1 (es)
BR (1) BR0315209A (es)
CA (1) CA2500366A1 (es)
EC (1) ECSP055725A (es)
MX (1) MXPA05003597A (es)
NO (1) NO20051651L (es)
NZ (1) NZ539862A (es)
OA (1) OA13142A (es)
PL (1) PL375071A1 (es)
WO (1) WO2004032639A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0410785D0 (en) 2004-05-14 2004-06-16 Glycologic Ltd Improved prebiotic
FR2877844B1 (fr) * 2004-11-18 2008-05-09 United Pharmaceuticals Sa Sa Composition contenant un probiotique destinee a l'alimentation infantile chez des sujets souffrant de diarrhees
CN101193559A (zh) * 2005-04-13 2008-06-04 雀巢技术公司 具有益生菌的婴儿配方食品
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007051475A1 (en) * 2005-11-04 2007-05-10 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
MX2008011958A (es) * 2006-03-29 2008-10-01 Nestec Sa Suplementos dieteticos que contienen probioticos.
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
MX2009003260A (es) 2006-10-02 2009-05-11 Danisco Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad.
ES2668552T3 (es) * 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2285387B1 (en) * 2008-06-13 2015-10-14 N.V. Nutricia Nutrition for prevention of infections
WO2009151315A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
US8425930B2 (en) * 2009-03-13 2013-04-23 The Regents Of The University Of California Prebiotic oligosaccharides
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
RU2600877C2 (ru) * 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NL2007931C2 (en) 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2015065194A1 (en) 2013-11-04 2015-05-07 N.V. Nutricia Fermented formula with non digestible oligosaccharides
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
EP3718418B1 (en) * 2014-08-08 2024-10-09 Société des Produits Nestlé S.A. Vitamin b2 and myo-inositol for treating and preventing gestational diabetes
MX374378B (es) * 2014-08-08 2025-03-06 Soc Des Produits Nestle S A Star Mioinositol y probioticos, y uso de estos.
US20210299193A1 (en) 2018-07-13 2021-09-30 Council Of Scientific & Industrial Research Synbiotic composition for improving immune response and antioxidant capacity during aging and a process for the preparation thereof
CN117223859B (zh) * 2023-10-11 2025-10-28 黑龙江飞鹤乳业有限公司 功能性组合物及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
WO1993010756A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US5834423A (en) * 1994-07-15 1998-11-10 Taiyo Kagaku Co., Ltd. Pharmaceutical composition containing sialic acid derivatives
FI102807B1 (fi) * 1994-08-25 1999-02-26 Valio Oy Lactobacillus rhamnosuksen käyttö elintarviketeollisuudessa klostridien estoon
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5688777A (en) * 1995-04-05 1997-11-18 Abbott Laboratories Inhibition of C. difficile infections by indigestible oligosaccharides
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6030650A (en) * 1996-11-22 2000-02-29 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US5902743A (en) * 1998-03-20 1999-05-11 Wisconsin Alumni Research Foundation Probiotic bifidobacterium strain
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
CN1229115C (zh) * 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances

Also Published As

Publication number Publication date
US20040072794A1 (en) 2004-04-15
AU2003282494A1 (en) 2004-05-04
PL375071A1 (en) 2005-11-14
CN1703149A (zh) 2005-11-30
OA13142A (en) 2006-12-13
CA2500366A1 (en) 2004-04-22
NO20051651L (no) 2005-05-06
NZ539862A (en) 2006-05-26
MXPA05003597A (es) 2005-06-03
EP1549151A1 (en) 2005-07-06
WO2004032639A1 (en) 2004-04-22
BR0315209A (pt) 2005-08-16

Similar Documents

Publication Publication Date Title
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
ATE369372T1 (de) 42-o-alkoxyalkylrapamycinderivate und diese enthaltende zusammensetzungen
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
ATE276746T1 (de) Orale darreichungsform enthaltend probiotische mikroorganismen
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
UY30030A1 (es) Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones
ATE322901T1 (de) Maca und geweih zur steigerung des testosteronspiegels
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
ECSP056201A (es) Triazolopirimidinas
BRPI0407176B8 (pt) composições compreendendo uma ou mais cepas de bifidobacterium e seus usos
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
ECSP056247A (es) Triazolopirimidinas
SE0300457D0 (sv) Novel compounds
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
DE602004005821D1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
BRPI0417205A (pt) composições farmacêuticas
TW200509794A (en) Novel anthelmintic and insecticidal compositions
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
IL173929A (en) Kahlalid F analogs and their pharmacy preparations
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
ATE369145T1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение